A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation.
Junya SuzukiKosuke KajiNorihisa NishimuraTakahiro KuboFumimasa TomookaAkihiko ShibamotoSatoshi IwaiYuki TsujiYukihisa FujinagaKoh KitagawaTadashi NamisakiTakemi AkahaneHitoshi YoshijiPublished in: Biomedicines (2023)
The renin-angiotensin-aldosterone system has gained attention due to its role as a mediator of liver fibrosis and hepatic stellate cell (HSC) activation. Meanwhile, the natriuretic peptide (NP) system, including atrial NP (ANP) and C-type NP (CNP), is a counter-regulatory hormone regulated by neprilysin. Although the combination of an angiotensin receptor and a neprilysin inhibitor (sacubitril/valsartan: SAC/VAL) has shown clinical efficacy in patients with heart failure, its potential effects on hepatic fibrosis have not been clarified. This study assessed the effects of SAC/VAL in carbon tetrachloride (CCl 4 )-induced murine liver fibrosis as well as the in vitro phenotypes of HSCs. Treatment with SAC and VAL markedly attenuated CCl 4 -induced liver fibrosis while reducing α-SMA + -HSC expansion and decreasing hepatic hydroxyproline and mRNA levels of pro-fibrogenic markers. Treatment with SAC increased plasma ANP and CNP levels in CCl 4 -treated mice, and ANP effectively suppressed cell proliferation and TGF-β-stimulated MMP2 and TIMP2 expression in LX-2 cells by activating guanylate cyclase-A/cGMP/protein kinase G signaling. Meanwhile, CNP did not affect the pro-fibrogenic activity of LX-2 cells. Moreover, VAL directly inhibited angiotensin II (AT-II)-stimulated cell proliferation and the expression of TIMP1 and CTGF through the blockade of the AT-II type 1 receptor/protein kinase C pathway. Collectively, SAC/VAL may be a novel therapeutic treatment for liver fibrosis.
Keyphrases
- liver fibrosis
- angiotensin ii
- angiotensin converting enzyme
- cell proliferation
- protein kinase
- vascular smooth muscle cells
- induced apoptosis
- poor prognosis
- cell cycle arrest
- nitric oxide
- signaling pathway
- type diabetes
- cell cycle
- metabolic syndrome
- endoplasmic reticulum stress
- heart failure
- skeletal muscle
- bone marrow
- long non coding rna
- working memory
- transforming growth factor
- mitral valve
- high fat diet induced